
Episode 438: 445. GLP1 CME
Oct 14, 2026 - 39:06
Radio and PodcastLive Radio & Podcasts
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV Trial Association between statin therapy as primary prevention...